TRPC6 and Alzheimer disease: TRPC6-dependent regulation of BDNF and endocannabinoids, has not been precisely studied in AD models, thus it is possible that these intracellular signaling pathways provide neuroprotective effects of described earlier TRPC6 agonists (including C20) in AD affected brains.